Akums Drugs Pharmaceuticals
Akums Drugs Pharmaceuticals Share Price Chart
Akums Drugs Pharmaceuticals last traded at ₹750.65 (2026-10-13). Over the past month the stock moved -0.4%, three months the stock moved +41.0%, year the stock moved +68.2%. Its closing range over 52 weeks is ₹420.00 – ₹823.00, with the latest close 8.8% below the high.
Closing prices up to 2026-10-13.
About Akums Drugs Pharmaceuticals
Established in 2004, Akums Drugs and Pharmaceuticals Limited is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services.[1]
Business Profile[1] Akums Drugs is a Contract Development and Manufacturing Organization (CDMO) manufacturing tablets, capsules, liquid orals, vials, ampoules, blow-filled seals, topical preparations, eye drops, dry powder injections, and gummies.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Akums Drugs Pharmaceuticals reported sales of ₹1,167.00 crore (+14.0%) and net profit of ₹101.00 crore (+55.4%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 1,167 | 175.00 | 15.00 | 101.00 | 6.35 |
| Mar 2026 | 1,158 | 152.00 | 13.00 | 81.00 | 5.38 |
| Dec 2025 | 1,160 | 147.00 | 13.00 | 68.00 | 4.21 |
| Sep 2025 | 1,018 | 94.00 | 9.00 | 43.00 | 2.59 |
| Jun 2025 | 1,024 | 129.00 | 13.00 | 65.00 | 4.03 |
| Mar 2025 | 1,056 | 94.00 | 9.00 | 150.00 | 9.38 |
| Dec 2024 | 1,010 | 121.00 | 12.00 | 66.00 | 4.14 |
| Sep 2024 | 1,033 | 121.00 | 12.00 | 67.00 | 4.14 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -12.5% | -6.7% | +11.9% | +0.5% | -1.5% | +14.9% | +9.7% | +14.0% |
| Operating profit growth | -20.4% | +30.1% | +3033.3% | +0.8% | -22.3% | +21.5% | +61.7% | +35.7% |
| Net profit growth | +103.0% | -66.2% | – | +6.6% | -35.8% | +3.0% | -46.0% | +55.4% |
| EPS growth | +86.5% | -69.4% | – | -1.2% | -37.4% | +1.7% | -42.6% | +57.6% |
| OPM % | 12.0% | 12.0% | 9.0% | 13.0% | 9.0% | 13.0% | 13.0% | 15.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Akums Drugs Pharmaceuticals reported sales of ₹4,359.00 crore (+5.9%) and net profit of ₹256.00 crore (-25.6%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 4,359 | 522.00 | 12.00 | 256.00 | 16.21 |
| Mar 2025 | 4,118 | 465.00 | 11.00 | 344.00 | 21.49 |
| Mar 2024 | 4,178 | 123.00 | 3.00 | 1.00 | -0.28 |
| Mar 2023 | 3,655 | 294.00 | 8.00 | 98.00 | 6.63 |
| Mar 2022 | 3,672 | -89.00 | -2.00 | -251.00 | -35.30 |
| Mar 2021 | 2,723 | 237.00 | 9.00 | 123.00 | 949.10 |
| Mar 2020 | 2,414 | 174.00 | 7.00 | 44.00 | 335.61 |
| Mar 2016 | 1,651 | 144.00 | 9.00 | 61.00 | 523.23 |
| Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +12.8% | +46.2% | +12.8% | +34.9% | -0.5% | +14.3% | -1.4% | +5.9% |
| Operating profit growth | +16.1% | +20.8% | +36.2% | -137.6% | – | -58.2% | +278.0% | +12.3% |
| Net profit growth | +41.9% | -27.9% | +179.5% | -304.1% | – | -99.0% | +34300.0% | -25.6% |
| EPS growth | +42.7% | -35.9% | +182.8% | -103.7% | – | -104.2% | – | -24.6% |
| OPM % | 9.0% | 7.0% | 9.0% | -2.0% | 8.0% | 3.0% | 11.0% | 12.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Akums Drugs Pharmaceuticals.
Get Free AI Stock Analysis FREE →Latest News
-
Akums Drugs & Pharmaceuticals Ltd Shows Bullish Momentum Amid Technical Upgrades
Frequently Asked Questions
What is the share price of Akums Drugs Pharmaceuticals today?
Akums Drugs Pharmaceuticals shares were last quoted at ₹750.65 (-0.2% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Akums Drugs Pharmaceuticals?
Akums Drugs Pharmaceuticals has a price-to-earnings (P/E) ratio of 44.20 and a price-to-book (P/B) ratio of 3.77. The industry P/E is 53.33.
What is the 52-week high and low of Akums Drugs Pharmaceuticals?
The 52-week high of Akums Drugs Pharmaceuticals is ₹839.25 and the 52-week low is ₹410.10.
What is the market cap of Akums Drugs Pharmaceuticals?
The market capitalisation of Akums Drugs Pharmaceuticals is about ₹12,891.35 crore.
How did Akums Drugs Pharmaceuticals perform in its latest quarterly results?
In the latest quarter (Jun 2026), Akums Drugs Pharmaceuticals reported sales of ₹1,167.00 crore (+14.0%) and net profit of ₹101.00 crore (+55.4%), compared with the same quarter last year.
Is Akums Drugs Pharmaceuticals a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Akums Drugs Pharmaceuticals has a 3-year ROE of 10.00%, 3-year profit growth of 29.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Akums Drugs Pharmaceuticals?
Promoters hold about 75.26% of Akums Drugs Pharmaceuticals.
Which sector does Akums Drugs Pharmaceuticals belong to?
Akums Drugs Pharmaceuticals belongs to the Pharmaceuticals & Drugs sector.